Exploring hub pyroptosis-related genes, molecular subtypes, and potential drugs in ankylosing spondylitis by comprehensive bioinformatics analysis and molecular docking

[1] Mauro D(2021)Ankylosing spondylitis: an autoimmune or autoinflammatory disease? Nat Rev Rheumatol 17 387-404

[2] Thomas R(2019)Secukinumab: a review in ankylosing spondylitis Drugs 79 433-443

[3] Guggino G(2021)Ankylosing spondylitis J Ophthalmic Vis Res 16 462-469

[4] Lories R(2020)New developments in our understanding of ankylosing spondylitis pathogenesis Immunology 161 94-102

[5] Brown MA(2017)Pathogenesis of ankylosing spondylitis - recent advances and future directions Nat Rev Rheumatol 13 359-367

[6] Ciccia F(2019)Ankylosing spondylitis: etiology, pathogenesis, and treatments Bone Res 7 22-8542

[7] Blair HA(2018)Influence of HLA-B27 on the ankylosing spondylitis phenotype: results from the REGISPONSER database Arthritis Res Ther 20 221-140

[8] Ebrahimiadib N(2019)Advances in nanomedicine for the treatment of ankylosing spondylitis Int J Nanomedicine 14 8521-1332

[9] Berijani S(2021)Serum metabolomics signatures associated with ankylosing spondylitis and TNF inhibitor therapy Front Immunol 12 630791-253

[10] Ghahari M(2020)Shotgun metagenomics reveals an enrichment of potentially cross-reactive bacterial epitopes in ankylosing spondylitis patients, as well as the effects of TNFi therapy upon microbiome composition Ann Rheum Dis 79 132-4329

[1] Mauro D(2021)Ankylosing spondylitis: an autoimmune or autoinflammatory disease? Nat Rev Rheumatol 17 387-404

[2] Thomas R(2019)Secukinumab: a review in ankylosing spondylitis Drugs 79 433-443

[3] Guggino G(2021)Ankylosing spondylitis J Ophthalmic Vis Res 16 462-469

[4] Lories R(2020)New developments in our understanding of ankylosing spondylitis pathogenesis Immunology 161 94-102

[5] Brown MA(2017)Pathogenesis of ankylosing spondylitis - recent advances and future directions Nat Rev Rheumatol 13 359-367

[6] Ciccia F(2019)Ankylosing spondylitis: etiology, pathogenesis, and treatments Bone Res 7 22-8542

[7] Blair HA(2018)Influence of HLA-B27 on the ankylosing spondylitis phenotype: results from the REGISPONSER database Arthritis Res Ther 20 221-140

[8] Ebrahimiadib N(2019)Advances in nanomedicine for the treatment of ankylosing spondylitis Int J Nanomedicine 14 8521-1332

[9] Berijani S(2021)Serum metabolomics signatures associated with ankylosing spondylitis and TNF inhibitor therapy Front Immunol 12 630791-253

[10] Ghahari M(2020)Shotgun metagenomics reveals an enrichment of potentially cross-reactive bacterial epitopes in ankylosing spondylitis patients, as well as the effects of TNFi therapy upon microbiome composition Ann Rheum Dis 79 132-4329